PUBLISHER: IMARC | PRODUCT CODE: 1521213
PUBLISHER: IMARC | PRODUCT CODE: 1521213
Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
The global anti-obesity drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.
Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They help reduce cravings and control compulsive eating, especially for sweets and fatty, salty, and high-calorie food products. They can also provide independent health benefits, such as controlling blood pressure, harmful lipid levels, waist circumference, sugar levels and nonalcoholic fatty liver disease (NAFLD) and minimize the risk of major cardiovascular diseases (CVDs) and progression of diabetic kidney disease.
Anti-Obesity Drugs Market Trends:
Recent advances in anti-obesity drugs have enabled the potential of attaining clinically significant weight loss among individuals. This, in confluence with the widespread prevalence of obesity on account of sedentary lifestyles, represents one of the key factors creating a positive outlook for the market. In addition, obesity increases the risk of developing type 2 diabetes (T2D), cardiovascular diseases (CVD), and cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney. It can also result in numerous psychological, neurological, pulmonary, gastrointestinal, renal, musculoskeletal, and endocrine diseases. Besides this, sleep deprivation, circadian desynchronization, chronic stress, and the rising use of anti-epileptic and psychotropic drugs may further induce weight gain. This, coupled with the increasing number of approvals of anti-obesity medications (AOMs) that help regulate appetite and food cravings, is fueling the growth of the market. Apart from this, weight loss aids in improving the quality of life, mobility, daily function, and psychological well-being of individuals. This, along with the increasing health consciousness, thriving pharmaceutical industry, and the rising focus on the management of diseases closely integrated with excess body weight, is anticipated to stimulate the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-obesity drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, drug type, and distribution channel.
Breakup by Drug Class:
Peripherally Acting Drugs
Centrally Acting Drugs
Breakup by Drug Type:
Prescription Drugs
OTC Drugs
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Breakup by Region:
Competitive Landscape:
Key Questions Answered in This Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
3 Executive Summary
4 Introduction
5 Global Anti-Obesity Drugs Market
6 Market Breakup by Drug Class
7 Market Breakup by Drug Type
8 Market Breakup by Distribution Channel
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
List of Figures
- Figure 1: Global: Anti-Obesity Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Anti-Obesity Drugs Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Anti-Obesity Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Anti-Obesity Drugs Market: Breakup by Drug Class (in %), 2023
- Figure 5: Global: Anti-Obesity Drugs Market: Breakup by Drug Type (in %), 2023
- Figure 6: Global: Anti-Obesity Drugs Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Anti-Obesity Drugs Market: Breakup by Region (in %), 2023
- Figure 8: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Anti-Obesity Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2018 & 2023
List of Tables
